Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts on Near Term Uotrends -- Ignore unavailable to you. Want to Upgrade?

To: Saulamanca who wrote (1292)	10/15/2009 4:40:03 PM
From: Paul Senior	Respond to of 1404

Yes, that one I'll have to look closer at. Looks like basically four drugs account for sales: "Clarithromycin accounted for 33.6% of total sales for the quarter ended June 30, 2009" I don't now if that drug is available to other Chinese companies in other brand names: en.wikipedia.org Operating income in '08 was $49.8M. That's expected to be down to $42-44M for fiscal '10, per management. That's a negative. OTOH, cash rules. (Sometimes) I'll consider.